Leeyen Hsu

616 total citations
12 papers, 439 citations indexed

About

Leeyen Hsu is a scholar working on Epidemiology, Hepatology and Emergency Medicine. According to data from OpenAlex, Leeyen Hsu has authored 12 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 2 papers in Emergency Medicine. Recurrent topics in Leeyen Hsu's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). Leeyen Hsu is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). Leeyen Hsu collaborates with scholars based in United States and Taiwan. Leeyen Hsu's co-authors include April W. Armstrong, Myron J. Tong, Lawrence M. Blatt, Sayuri P. Jinadasa, Jisha Joshua, Ryan J. Anderson, Rebecca Sell, Daniel Talmor, Jeremy R. Beitler and Ariel Mueller and has published in prestigious journals such as Gastroenterology, Hepatology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Leeyen Hsu

12 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leeyen Hsu United States 9 181 159 115 75 56 12 439
Shan Yuan United States 10 89 0.5× 30 0.2× 51 0.4× 45 0.6× 35 0.6× 16 418
W. M. Smid Netherlands 13 58 0.3× 37 0.2× 35 0.3× 28 0.4× 59 1.1× 37 558
Manuel Jesús Romero-Jiménez Spain 11 51 0.3× 20 0.1× 31 0.3× 20 0.3× 23 0.4× 24 508
Yecheskel Schneider United States 14 158 0.9× 61 0.4× 42 0.4× 6 0.1× 169 3.0× 62 668
Michele Imparato Italy 12 303 1.7× 340 2.1× 8 0.1× 16 0.2× 37 0.7× 20 510
Rossana Fontana Italy 8 164 0.9× 134 0.8× 41 0.4× 4 0.1× 64 1.1× 9 616
Nikolaos Papadopoulos Greece 13 359 2.0× 255 1.6× 27 0.2× 15 0.2× 26 0.5× 45 618
Sujith Subesinghe United Kingdom 13 126 0.7× 37 0.2× 157 1.4× 20 0.3× 54 1.0× 26 720
Chiara Barbieri Italy 10 83 0.5× 8 0.1× 57 0.5× 14 0.2× 93 1.7× 15 443
Su Rin Shin South Korea 9 121 0.7× 108 0.7× 18 0.2× 10 0.1× 116 2.1× 22 465

Countries citing papers authored by Leeyen Hsu

Since Specialization
Citations

This map shows the geographic impact of Leeyen Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leeyen Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leeyen Hsu more than expected).

Fields of papers citing papers by Leeyen Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leeyen Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leeyen Hsu. The network helps show where Leeyen Hsu may publish in the future.

Co-authorship network of co-authors of Leeyen Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Leeyen Hsu. A scholar is included among the top collaborators of Leeyen Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leeyen Hsu. Leeyen Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Anderson, Ryan J., Sayuri P. Jinadasa, Leeyen Hsu, et al.. (2018). Shock subtypes by left ventricular ejection fraction following out-of-hospital cardiac arrest. Critical Care. 22(1). 162–162. 21 indexed citations
2.
Beitler, Jeremy R., Sayuri P. Jinadasa, Ariel Mueller, et al.. (2017). Favorable Neurocognitive Outcome with Low Tidal Volume Ventilation after Cardiac Arrest. American Journal of Respiratory and Critical Care Medicine. 195(9). 1198–1206. 68 indexed citations
3.
Hsu, Leeyen & April W. Armstrong. (2014). JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis. Journal of Immunology Research. 2014. 1–7. 109 indexed citations
4.
Hsu, Leeyen & April W. Armstrong. (2013). Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response. Expert Review of Clinical Immunology. 9(10). 949–958. 50 indexed citations
5.
Hsu, Leeyen, Christopher L. Bowlus, Susan L. Stewart, et al.. (2012). Electronic Messages Increase Hepatitis B Screening in At-Risk Asian American Patients: A Randomized, Controlled Trial. Digestive Diseases and Sciences. 58(3). 807–814. 49 indexed citations
6.
Tong, Myron J., et al.. (2012). Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma.. PubMed. 8(12). 808–19. 7 indexed citations
7.
Tong, Myron J., Leeyen Hsu, Patrick Chang, & Lawrence M. Blatt. (2011). Evaluation of current treatment recommendations for chronic hepatitis B: A 2011 update. Journal of Gastroenterology and Hepatology. 26(5). 829–835. 23 indexed citations
8.
Tong, Myron J., Leeyen Hsu, Jia‐Horng Kao, et al.. (2010). A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International. 4(2). 516–522. 14 indexed citations
9.
Tong, Myron J., Jia‐Horng Kao, Leeyen Hsu, et al.. (2009). Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis. Digestive Diseases and Sciences. 54(6). 1337–1346. 27 indexed citations
10.
Tong, Myron J., et al.. (2008). Treatment recommendations for chronic hepatitis B. Hepatology. 48(4). 1070–1078. 69 indexed citations
11.
Tong, Myron J., et al.. (2008). Do guidelines preclude hepatitis B patients from receiving treatment? #. Hepatology. 49(2). 701–702. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026